Lirimilast

(Synonyms: BAY 19-8004)
Customer Review

Based on 1 Customer Validation

Lirimilast (BAY 19-8004) is a potent, selective and orally active phosphodiesterase-4 (PDE4) inhibitor with an IC50 value of 49 nM. Lirimilast can be used for the treatment of asthma or chronic obstructive pulmonary disease (COPD). Lirimilast has potently anti-inflammatory properties.

For research use only. We do not sell to patients.

  • Purity: 98.69%
  • CAS No.: 329306-27-6
  • Formula: C17H12Cl2N2O6S
  • Molecular Weight:443.26
  • Storage:
    Powder   -20°C, 3 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs

All Phosphodiesterase (PDE) Isoforms

More
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00